Cardinal Health (CAH) FY2012 results: revenue $107.6 billion, up 4.8% on the year
Cardinal Health Inc. (CAH) reported revenue of $107.6 billion for fiscal 2012, the year ended 30 June 2012, up 4.8% on the year before. Net income was $1.1 billion, up 11.5%, and diluted earnings per share $3.06. The figures are the company's own, from the 10-K it filed with the SEC on 22 August 2012.
Revenue
$107.6 billion
+4.8% on the year
FY2008FY2012
Operating margin
1.7%
1.5% a year earlier
FY2008FY2012
Net income
$1.1 billion
+11.5% on the year
FY2008FY2012
Diluted EPS
$3.06
+12.5% on the year
FY2008FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
107,552
102,644
98,503
+4.8%
Cost of revenue
103,011
98,482
94,722
+4.6%
Gross profit
4,541
4,162
3,781
+9.1%
Gross margin
4.2%
4.1%
3.8%
Selling, general and administrative
2,677
2,528
2,397
+5.9%
Operating income
1,792
1,514
1,307
+18.4%
Operating margin
1.7%
1.5%
1.3%
Interest expense
95.0
93.0
113
+2.2%
Pre-tax income
1,698
1,518
1,212
+11.8%
Income tax
628
552
625
+13.7%
Effective tax rate
37.0%
36.4%
51.6%
Net income
1,069
959
642
+11.5%
Net margin
1.0%
0.9%
0.7%
Diluted EPS
$3.06
$2.72
$1.77
+12.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
1,176
1,395
2,134
-15.7%
Capital expenditure
260
291
260
-10.7%
Free cash flow
916
1,103
1,874
-17.0%
Free cash flow margin
0.9%
1.1%
1.9%
Cash from investing
-377
-2,028
127
Cash from financing
-454
-193
-728
Depreciation and amortisation
325
313
254
+3.8%
Share-based compensation
85.0
80.0
100
+6.2%
Buybacks
450
270
230
+66.8%
Dividends paid
300
274
253
+9.4%
Dividend per share
$0.86
$0.78
$0.70
+10.3%
Diluted shares, weighted
349m
352m
361m
-1.0%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
6,244
5,849
5,276
+6.8%
Debt
2,894
2,502
2,129
+15.7%
Other liabilities
15,122
14,495
12,585
+4.3%
Total liabilities and equity
24,260
22,846
19,990
+6.2%
Fixed assets
1,551
1,512
1,469
+2.6%
Goodwill
3,978
3,846
2,205
+3.4%
Intangible assets
414
413
47.8
+0.1%
Investments
n/a
0.0
692
Cash and equivalents
2,274
1,929
2,755
+17.9%
Receivables
6,355
6,156
5,171
+3.2%
Inventory
7,864
7,334
6,356
+7.2%
Other assets
1,824
1,656
1,295
+10.2%
Total assets
24,260
22,846
19,990
+6.2%
10-K for the year ended 30 June 2012, filed 22 August 2012: the filing.